Stock FAQs

astrazeneca vaccine stock price

by Aleen Fahey Published 3 years ago Updated 2 years ago
image

$66.72

See more

image

Is AZN a good stock to buy now?

The financial health and growth prospects of AZN, demonstrate its potential to outperform the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.

Is AstraZeneca a publicly traded company?

On what stock exchange is AstraZeneca traded and what is the stock symbol? AstraZeneca is traded on the London, Stockholm and Nasdaq exchanges. The symbol is AZN in all three markets.

What is the future of AstraZeneca share price?

AstraZeneca PLC (NASDAQ:AZN) The 23 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 72.16, with a high estimate of 93.89 and a low estimate of 57.73. The median estimate represents a +10.57% increase from the last price of 65.26.

Why is AstraZeneca stock down?

AstraZeneca Stock Declines After Earnings Report The company reiterated its full-year guidance, but it looks that the market expected that it would set more aggressive targets. AstraZeneca has also stated that it would begin to sell its coronavirus vaccine for a profit.

Is AstraZeneca and Covishield same?

Effectiveness: The same vaccine is generally used for all doses in a vaccine series because that is usually how the vaccine is studied by the vaccine companies. In clinical trials, the AstraZeneca/COVISHIELD COVID-19 vaccine prevented 60% to 80% of sickness from COVID-19 starting two weeks after the second dose.

Who owns AstraZeneca shares?

The company is a wholly owned subsidiary of AstraZeneca plc, a United Kingdom-based pharmaceutical company.

Will AstraZeneca shares go up?

Management anticipates total sales to increase by a percentage in the high teens and core earnings per share are forecast to rise by a mid-to-high percentage in the twenties. AstraZeneca shares are up 38% in the past 12 months to £106.88 thanks to the Covid fillip and up 52% since January 2021.

Is AstraZeneca overvalued?

Pharma company AstraZeneca (NASDAQ:AZN) has had a strong run of late, but I now consider it overvalued and would not be surprised to see a fallback in share price.

Why is AstraZeneca stock down in India?

In 15 cases blood clot in veins and in 22 cases blood clot formation in lungs were found in European Union and Britain said the administrators who administered the Vaccine Program. Following which the rollercoaster of AstraZeneca share price started which affected AZPIL share in India too.

Why is AstraZeneca share price so high?

AstraZeneca shares rise on record revenue and promising new treatments. The AstraZeneca share price is rising as the British-Swedish pharmaceutical giant achieves record quarterly and full-year revenue. And innovative cancer treatments could see it strike a new high in 2022.

Is AstraZeneca a good stock to buy in India?

Is Astrazeneca Pharma India Ltd a good quality company? Past 10 year's financial track record analysis by Moneyworks4me indicates that Astrazeneca Pharma India Ltd is a average quality company.

Is AstraZeneca listed in India?

AstraZeneca Pharma I Listing Information The Listing Page of AstraZeneca Pharma India Ltd. presents the Incorporation Date, Public Issue Date, Book Closure dates, Face Value, Key Listing information, Indices it is a part of, and the Exchanges where the company is listed. Bangalore Stock Exchange Ltd.

Is AstraZeneca a Fortune 500?

RANK462. The pharmaceutical giant, based in Cambridge, England, had a roller-coaster year. The company emerged as an early front-runner in the race to develop a COVID-19 vaccine, thanks to a savvy partnership with researchers at the University of Oxford.

Which country manufactures AstraZeneca vaccine?

AstraZeneca's COVID-19 vaccine manufactured in Thailand has been authorised under the World Health Organization (WHO) Emergency Use Listing (EUL) procedure, with immediate effect.

Who are AstraZeneca competitors?

Competitor comparisonJohnson & Johnson Headquarters. United States of America. No. of employees. 141,700. ... Pfizer Inc Headquarters. United States of America. No. of employees. 79,000. ... F. Hoffmann-La Roche Ltd Headquarters. Switzerland. No. of employees. ... AbbVie Inc Headquarters. United States of America. No. of employees. 50,000.

How many countries does AstraZeneca operate in?

AstraZeneca has sales offices in 19 countries and sells via suppliers in 29 additional countries.

What's the AstraZeneca share price today?

AstraZeneca share price was Rs 2,938.45 as on 10 Jun, 2022, 03:59 PM IST. AstraZeneca share price was down by 1.37% based on previous share price o...

Who are the peers for AstraZeneca in Pharmaceuticals sector?

Top 5 Peers for AstraZeneca are Procter & Gamble Health Ltd., Sanofi India Ltd., Pfizer Ltd., GlaxoSmithKline Pharmaceuticals Ltd. and Abbott India...

Who's the owner of AstraZeneca?

Promoter,DII and FII owns 75.0, 1.14 and 2.38 shares of AstraZeneca as on 31 Mar 2022There is no change in promoter holding from 31 Dec 2021 to 31...

What's the market capitalization of AstraZeneca?

Within the Pharmaceuticals sector, AstraZeneca stock has a market cap rank of 27. AstraZeneca has a market cap of Rs 7,346.13 Cr.

What are the revenue and earnings for AstraZeneca ?

Total Revenue and Earning for AstraZeneca for the year ending 2022-03-31 was Rs 820.36 Cr and Rs 61.59 Cr on Standalone basis. Last Quarter 2022-03...

What is AstraZeneca's 52 week high / low?

AstraZeneca share price saw a 52 week high of Rs 3,900.00 and 52 week low of Rs 2,445.70.

What are the key metrics to analyse AstraZeneca Share Price?

Key Metrics for AstraZeneca are: PE Ratio of AstraZeneca is 119.27 Earning per share of AstraZeneca is 24.64 Price/Sales ratio of AstraZeneca is 7....

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9